St. Jude Gets FDA Approval for Epiducer Neurostimulation Delivery System

St. Jude Medical has received FDA clearance for its Epiducer neurostimulation lead delivery system for pain management, according to a company news release.

Advertisement

 

The Epiducer system allows placement of as many as three neurostimulation leads through a single entry point.

 

The system also allows introduction of St. Jude Medical S-Series paddle leads through a percutaneous entry.

 

Read the St. Jude Medical release on approval of Epiducer.

 

Related Articles on Neurostimulation Therapy:

5 Keys for Pain Management Physicians to Ensure Success in 2011

Neurostimulation System Shows Positive Findings in Treating Cluster Headache

Study: Peripheral Nerve Stimulation Reduces Migraines

 

 

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.